Danaher Acquires Masimo
Masimo will operate as a stand-alone business within the Danaher diagnostics segment, focusing on patient monitoring and pulse oximetry.
Masimo will operate as a stand-alone business within the Danaher diagnostics segment, focusing on patient monitoring and pulse oximetry.
Epitel's REMI Vigilenz AI For Bedside Notifications has received FDA 510(k) clearance, notifying clinicians of potential seizures.
Icentia has received U.S. FDA clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that uses a wireless, single-use recorder.Â
Masimo will operate as a stand-alone business within the Danaher diagnostics segment, focusing on patient monitoring and pulse oximetry.
Smith+Nephew announced that its LEAF Patient Monitoring System received an innovative technology designation.
Read MoreOpticyte’s Cell Oâ‚‚ Patient Monitor has received Breakthrough Device Designation for the continuous monitoring of those at risk of organ failure.
Read MoreBioIntelliSense has launched a pulse oximetry sensor chipset aimed at improving the technology’s sensitivity to skin-color.
Read MoreB-Secur teamed up with Life Science Partner to consummate partnerships with medical device and digital cardiology monitoring companies.
Read MoreThe U.S. FDA has identified one patient death that was tied to the use of Integra LifeSciences CereLink ICP monitors.
Read MoreIntegra LifeSciences initiated the global product removal of pressure monitor devices following consultation with the U.S. FDA.
Read More
Inspira Technologies signed an agreement with Glo-Med Networks for the distribution of its new HYLA blood device and disposable units.